Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.JCRC.2024.154901 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
This study investigated fluid removal strategies for critically ill patients with fluid overload on mechanical ventilation. Traditionally, a negative fluid balance (FB) is aimed for. However, this approach can have drawbacks. Here, we compared a new approach, namely removing fluids until patients become fluid responsive (FR) to the traditional empiric negative balance approach. Twelve patients were placed in each group (n = 24). FR assessment was performed using passive leg raising (PLR). Both groups maintained stable blood pressure and heart function during fluid management. Notably, the FR group weaned from the ventilator significantly faster than negative FB group (both for a spontaneous breathing trial (14 h vs. 36 h, p = 0.031) and extubation (26 h vs. 57 h, p = 0.007); the difference in total ventilator time wasn't statistically significant (49 h vs. 62 h, p = 0.065). Additionally, FR group avoided metabolic problems like secondary alkalosis and potential hypokalemia seen in the negative FB group. FR-guided fluid-removal in fluid overloaded mechanically ventilated patients was a feasible, safe, and maybe superior strategy in facilitating weaning and disconnection from mechanical ventilation than negative FB-driven fluid removal. FR is a safe endpoint for optimizing cardiac function and preventing adverse consequences during fluid removal.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | CASTRO-LOPEZ, RICARDO ADOLFO | Hombre |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 2 | Born, Pablo | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 3 | Roessler, Eric | Hombre |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 4 | Labra, Christian | - |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 5 | MCNAB-MARTIN, PAUL | Hombre |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 6 | BRAVO-GRAU, SEBASTIAN | Hombre |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 7 | SOTO-MUNOZ, DAGOBERTO IGOR | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 8 | Kattan, Eduardo | - |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 9 | HERNANDEZ-POBLETE, GLENN | Hombre |
Pontificia Universidad Católica de Chile - Chile
Hospital Clínico UC-Christus - Chile |
| 10 | Bakker, Jan | - |
Pontificia Universidad Católica de Chile - Chile
Erasmus MC Univ Med Ctr - Países Bajos Erasmus MC - Países Bajos |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Agencia Nacional de Investigación y Desarrollo |
| ICU |
| Agencia Nacional de Investigacion y Desarrollo (ANID) , Chile |
| Agradecimiento |
|---|
| This work was supported by FONDECYT grant N degrees 1200248 from the Agencia Nacional de Investigacion y Desarrollo (ANID) , Chile. |
| This was a physiological, unicentric, randomized controlled trial. Patient data were obtained from the FLOW protocol (clinicaltrials.gov identifier NCT04496583) authorized by the Ethics Committee and Institutional Review Board (approval ID 201015001\u20132021). This project received financial support from FONDECYT grant No. 1200248, provided by the Agencia Nacional de Investigaci\u00F3n y Desarrollo (ANID), Chile. Patients were prospectively recruited between 2021 and 2024, after admission to the ICU within a leading academic tertiary care facility for medical or postsurgical care.This work was supported by FONDECYT grant N\u00B0 1200248 from the Agencia Nacional de Investigaci\u00F3n y Desarrollo (ANID), Chile. |
| This was a physiological, unicentric, randomized controlled trial. Patient data were obtained from the FLOW protocol (clinicaltrials.gov identifier NCT04496583) authorized by the Ethics Committee and Institutional Review Board (approval ID 201015001\u20132021). This project received financial support from FONDECYT grant No. 1200248, provided by the Agencia Nacional de Investigaci\u00F3n y Desarrollo (ANID), Chile. Patients were prospectively recruited between 2021 and 2024, after admission to the ICU within a leading academic tertiary care facility for medical or postsurgical care.This work was supported by FONDECYT grant N\u00B0 1200248 from the Agencia Nacional de Investigaci\u00F3n y Desarrollo (ANID), Chile. |